157 related articles for article (PubMed ID: 35226074)
1. CRESSP: a comprehensive pipeline for prediction of immunopathogenic SARS-CoV-2 epitopes using structural properties of proteins.
An H; Eun M; Yi J; Park J
Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35226074
[TBL] [Abstract][Full Text] [Related]
2. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
[TBL] [Abstract][Full Text] [Related]
3. Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins.
Devi YD; Goswami HB; Konwar S; Doley C; Dolley A; Devi A; Chongtham C; Dowerah D; Biswa V; Jamir L; Kumar A; Satapathy SS; Ray SK; Deka RC; Doley R; Mandal M; Das S; Singh CS; Borah PP; Nath P; Namsa ND
PLoS One; 2021; 16(11):e0258645. PubMed ID: 34780495
[TBL] [Abstract][Full Text] [Related]
4. Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: An in silico approach.
Obando-Pereda G
J Med Virol; 2021 Sep; 93(9):5350-5357. PubMed ID: 33913542
[TBL] [Abstract][Full Text] [Related]
5. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
Reche PA
Front Immunol; 2020; 11():586984. PubMed ID: 33178220
[TBL] [Abstract][Full Text] [Related]
6. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
Front Immunol; 2021; 12():692937. PubMed ID: 34497604
[TBL] [Abstract][Full Text] [Related]
7. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
[TBL] [Abstract][Full Text] [Related]
8. BCEPS: A Web Server to Predict Linear B Cell Epitopes with Enhanced Immunogenicity and Cross-Reactivity.
Ras-Carmona A; Pelaez-Prestel HF; Lafuente EM; Reche PA
Cells; 2021 Oct; 10(10):. PubMed ID: 34685724
[TBL] [Abstract][Full Text] [Related]
9. Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses.
Balz K; Kaushik A; Chen M; Cemic F; Heger V; Renz H; Nadeau K; Skevaki C
Sci Rep; 2021 Feb; 11(1):4792. PubMed ID: 33637823
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2.
Kiyotani K; Toyoshima Y; Nemoto K; Nakamura Y
J Hum Genet; 2020 Jul; 65(7):569-575. PubMed ID: 32372051
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
[TBL] [Abstract][Full Text] [Related]
12. Population-Predicted MHC Class II Epitope Presentation of SARS-CoV-2 Structural Proteins Correlates to the Case Fatality Rates of COVID-19 in Different Countries.
Liang C; Bencurova E; Psota E; Neurgaonkar P; Prelog M; Scheller C; Dandekar T
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807854
[TBL] [Abstract][Full Text] [Related]
13. The landscape of antibody binding in SARS-CoV-2 infection.
Heffron AS; McIlwain SJ; Amjadi MF; Baker DA; Khullar S; Armbrust T; Halfmann PJ; Kawaoka Y; Sethi AK; Palmenberg AC; Shelef MA; O'Connor DH; Ong IM
PLoS Biol; 2021 Jun; 19(6):e3001265. PubMed ID: 34143766
[TBL] [Abstract][Full Text] [Related]
14. Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions?
Karagöz IK; Munk MR; Kaya M; Rückert R; Yıldırım M; Karabaş L
Exp Eye Res; 2021 Feb; 203():108433. PubMed ID: 33400927
[TBL] [Abstract][Full Text] [Related]
15. Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach.
Adhikari UK; Rahman MM
Infect Genet Evol; 2017 Dec; 56():75-91. PubMed ID: 29107145
[TBL] [Abstract][Full Text] [Related]
16. Introducing of an integrated artificial neural network and Chou's pseudo amino acid composition approach for computational epitope-mapping of Crimean-Congo haemorrhagic fever virus antigens.
Nosrati M; Mohabatkar H; Behbahani M
Int Immunopharmacol; 2020 Jan; 78():106020. PubMed ID: 31776090
[TBL] [Abstract][Full Text] [Related]
17. Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization.
Ragone C; Mauriello A; Cavalluzzo B; Cavalcanti E; Russo L; Manolio C; Mangano S; Cembrola B; Tagliamonte M; Buonaguro L
Front Immunol; 2024; 15():1398002. PubMed ID: 38947322
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
[TBL] [Abstract][Full Text] [Related]
19. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
Yang Z; Bogdan P; Nazarian S
Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
[TBL] [Abstract][Full Text] [Related]
20. In silico analysis of MHC-I restricted epitopes of Chikungunya virus proteins: Implication in understanding anti-CHIKV CD8(+) T cell response and advancement of epitope based immunotherapy for CHIKV infection.
Pratheek BM; Suryawanshi AR; Chattopadhyay S; Chattopadhyay S
Infect Genet Evol; 2015 Apr; 31():118-26. PubMed ID: 25643869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
